CVN636

• CAT Number: I041135
• CAS Number: 2226732-62-1
• Molecular Formula: C19H20FNO4S
• Molecular Weight: 377.43
• Purity: ≥95%
• Synonyms: (2S)-2-(4-fluorophenyl)-N-[(3S,4S)-4-methylsulfonyl-3,4-dihydro-2H-chromen-3-yl]propanamide
• InChI: InChI=1S/C19H20FNO4S/c1-12(13-7-9-14(20)10-8-13)19(22)21-16-11-25-17-6-4-3-5-15(17)18(16)26(2,23)24/h3-10,12,16,18H,11H2,1-2H3,(H,21,22)/t12-,16-,18-/m0/s1
• InChIKey: DKLUNKKXISSMIY-IWEFOYFVSA-N
• SMILES: C[C@@H](C1=CC=C(C=C1)F)C(=O)N[C@H]2COC3=CC=CC=C3[C@@H]2S(=O)(=O)C

CVN636（Cat No.:I041135）is a potent small molecule inhibitor targeting the protein kinase CK2 (casein kinase 2), which plays a key role in regulating cell survival, growth, and proliferation. By inhibiting CK2 activity, CVN636 disrupts several cellular pathways involved in cancer progression, inflammation, and other diseases associated with abnormal kinase signaling. This compound has shown promise in preclinical studies for its ability to reduce tumor growth and enhance the effectiveness of other cancer therapies. CVN636 is being explored as a potential therapeutic candidate for targeting CK2-driven diseases, including various cancers and inflammatory disorders.